Articles

Farnesyltransferase inhibitor tipifarnib inhibits Rheb prenylation and stabilizes Bax in acute myelogenous leukemia cells

Division of Oncology Research, Department of Oncology
Division of Oncology Research, Department of Oncology
Division of Oncology Research, Department of Oncology;Department of Molecular Pharmacology and Experimental Therapeutics
Division of Oncology Research, Department of Oncology
Division of Oncology Research, Department of Oncology
Division of Oncology Research, Department of Oncology
Division of Oncology Research, Department of Oncology
Division of Biomedical Statistics, Department of Health Sciences Research
Division of Biomedical Statistics, Department of Health Sciences Research
Division of Gastroenterology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN
Division of Gastroenterology, Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN
Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY
Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, MD, USA
Division of Oncology Research, Department of Oncology
Division of Oncology Research, Department of Oncology;Department of Molecular Pharmacology and Experimental Therapeutics
Vol. 99 No. 1 (2014): January, 2014 https://doi.org/10.3324/haematol.2013.087734